Date published: 2026-5-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

VPAC2 Activators

The chemical class known as VPAC2 Activators encompasses a range of molecules capable of binding and activating the VPAC2 receptor, either directly or indirectly. Direct activators are often synthetic analogs or peptides that share structural similarities with VIP or PACAP, enabling them to engage with the receptor and elicit a biological response. These molecules bind to the VPAC2 receptor and mimic the natural ligands' ability to activate downstream signaling pathways, predominantly the cAMP-PKA pathway, which leads to a variety of physiological effects including vasodilation, glycogenolysis, and modulation of immune responses.

Indirect activators may not bind directly to VPAC2 but influence intracellular pathways that enhance the receptor's natural activation. Such compounds include those that increase intracellular cAMP levels, such as forskolin, which directly stimulates adenylyl cyclase, or phosphodiesterase inhibitors, which prevent cAMP degradation. By elevating cAMP, these compounds can potentiate the signaling cascade downstream of VPAC2 activation, effectively amplifying the receptor's physiological roles.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Although traditionally an adenylyl cyclase activator, it can increase cAMP levels and may indirectly enhance VPAC2 signaling.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

A non-selective beta-adrenergic agonist that raises cAMP levels, potentially increasing the sensitivity of VPAC2.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Another phosphodiesterase inhibitor that increases cAMP levels, potentially enhancing VPAC2 signaling.

Salbutamol

18559-94-9sc-253527
sc-253527A
25 mg
50 mg
$94.00
$141.00
(1)

A beta2-adrenergic agonist that increases cAMP and may indirectly activate VPAC2.